BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 735686)

  • 21. Drug-induced liver injury.
    van Berge Henegouwen GP; Vogten AJ
    Neth J Med; 1980; 23(1):23-32. PubMed ID: 6988728
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hepatotoxic side-effects of rifampicin; a comparative clinical study (author's transl)].
    Kuntz HD; Rausch V
    Prax Klin Pneumol; 1977 Nov; 31(11):925-32. PubMed ID: 928291
    [No Abstract]   [Full Text] [Related]  

  • 23. Toxicological implications of drug metabolism.
    Welch RM
    Pharmacol Rev; 1978 Dec; 30(4):457-67. PubMed ID: 392540
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hepatic metabolism of foreign substances. Enzymatic hydroxylation system of hepatic microsomes and of cytochrome P-450].
    Valla D
    Med Chir Dig; 1978; 7(3):259-62, 265-6. PubMed ID: 28455
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug-induced hepatitis during a treatment associating isoniazid and rifampicin].
    Jean R; Bonnet H; Pages P; Dumas R; Greze J
    Ann Pediatr (Paris); 1972 Apr; 19(4):307-11. PubMed ID: 5075678
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
    Poupon RY; Meyniel D; Petit J; Gustot P; Darnis F
    Ann Med Interne (Paris); 1979; 130(6-7):371-5. PubMed ID: 496138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reversible acute hepatic failure after treatment with association of isoniazide-rifampicin (author's transl)].
    Le Guillou M; L'Henaff F; Boisseau M; Castaing Y; Bourdalle-Badie C
    Sem Hop; 1981 Jun 18-25; 57(25-28):1199-201. PubMed ID: 6266037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drugs in liver disease.
    Branch RA
    Clin Pharmacol Ther; 1998 Oct; 64(4):462-5. PubMed ID: 9797803
    [No Abstract]   [Full Text] [Related]  

  • 30. Dantrolene sodium: urinary metabolites and hepatotoxicity.
    Arnold TH; Epps JM; Cook HR; Hamrick ME
    Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):381-98. PubMed ID: 6856946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of metabolic activation in drug-induced hepatotoxicity.
    Park BK; Kitteringham NR; Maggs JL; Pirmohamed M; Williams DP
    Annu Rev Pharmacol Toxicol; 2005; 45():177-202. PubMed ID: 15822174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug metabolism in the production of liver injury.
    Mitchell JR; Potter WZ
    Med Clin North Am; 1975 Jul; 59(4):877-85. PubMed ID: 238084
    [No Abstract]   [Full Text] [Related]  

  • 33. [Nature of the hepatotoxic action of isoniazid (review of the literature)].
    Skakun NP; Shman'ko VV
    Vrach Delo; 1984 Jan; (1):49-52. PubMed ID: 6367216
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolic activation: biochemical basis for many drug-induced liver injuries.
    Mitchell JR; Nelson SD; Thorgeirsson SS; McMurtry RJ; Dybing E
    Prog Liver Dis; 1976; 5():259-79. PubMed ID: 775543
    [No Abstract]   [Full Text] [Related]  

  • 35. Drugs and the ageing liver.
    James OF
    J Hepatol; 1985; 1(4):431-5. PubMed ID: 3902953
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical pharmacologic aspects of cytochrome P-450 dependent biotransformation of drugs].
    Ackermann E
    Pharmazie; 1978 Jul; 33(7):400-6. PubMed ID: 364493
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatic injury and drug metabolism in patients with alpha-methyldopa-induced liver damage.
    Sotaniemi EA; Hokkanen OT; Ahokas JT; Pelkonen RO; Ahlqvist J
    Eur J Clin Pharmacol; 1977 Dec; 12(6):429-35. PubMed ID: 598417
    [No Abstract]   [Full Text] [Related]  

  • 38. Enzyme induction.
    Dollery CT
    Br J Anaesth; 1972 Sep; 44(9):961-6. PubMed ID: 4564266
    [No Abstract]   [Full Text] [Related]  

  • 39. [The role of cytochrome P450 in the activation of drugs (author's transl)].
    Ullrich V
    Arzneimittelforschung; 1977; 27(96):1821-7. PubMed ID: 579147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug Metabolism in the Liver.
    Almazroo OA; Miah MK; Venkataramanan R
    Clin Liver Dis; 2017 Feb; 21(1):1-20. PubMed ID: 27842765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.